Jul 22, 2020
Michael J. Daugherty, is the President of
LabMD, an Atlanta-based clinical and anatomic medical
laboratory as well as CEO of AnyLabTestNow in Virginia. LabMD
specializes in analysis and diagnosis of blood, urine, and tissue
specimens for cancers, micro-organisms and tumor markers. He has 20
years experience in diagnostic laboratory medicine. He is author of
The Devil Inside the Beltway: The Shocking Expose of the US
Government's Surveillance and Overreach Into Cybersecurity,
Medicine and Small Business.
U.S. health officials and drugmakers expect to start producing potential coronavirus vaccine doses by the end of the summer, a senior administration official said Monday.
The U.S. is aiming to deliver 300 million doses of a vaccine for Covid-19 by early 2021. The manufacturing process is already underway even though they aren’t sure which vaccine, if any, will work, a senior Trump administration official told reporters on a conference call Monday. He said they are already buying equipment, securing the manufacturing sites and, in some cases, acquiring the raw materials.
“Exactly when the vaccine materials will be in production and manufacturing? It’s probably four to six weeks away,” the official said on the call, which was hosted by the Department of Health and Human Services. “But we will be actively manufacturing by the end of the summer.”